Therapeutic Insight



Therapeutic Insight: Sepsis, a National Healthcare Crisis


  • Timothy G. Buchman, PhD, MD, Special Advisor, Biomedical Advanced Research and Development Authority (BARDA)
  • Clifford S. Deutschman, MS, MD, MCCM, Vice Chair, Research, Department of Pediatrics, Cohen Children’s Medical Center


Moderator: Ed Saltzman, Executive Chairman, Defined Health

Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies: What’s In, What’s Out, What’s Up-and-Coming


  • Michael Aberman, MD, MBA, President and CEO, Quentis Therapeutics, Inc.
  • Christopher Mortko, PhD, Head, Headquarters Search and Evaluation, Merck
  • Michael Quigley, PhD, Executive Director, Lead, Oncology Discovery Biology, Bristol-Myers Squibb
  • Dmitriy Zamarin, MD, PhD, Assistant Attending Physician, Gynecologic Medical Oncology, Immunotherapetics Service, Memorial Sloan-Kettering Cancer Center


Moderator: Jeffrey M. Bockman, PhD, SVP, Head of Oncology Practice, Defined Health

Therapeutic Insight: “Metabesity” – A New Path for Drug Development in Metabolic Disease? 


  • Chuck Gray, Director of Search and Evaluation, Global Drug Discovery, Novo Nordisk A/S
  • Thomas C. Seoh, President & Chief Executive Officer, Kinexum
  • Michael B. Zemel,PhD, Chief Scientific Officer, NuSirt Biopharma


Moderator: Danielle M. Marra, MS, MBA, Associate Principal, Defined Health